
Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards
Read More21 - 25 of 155 results
In this video interview with Manufacturing Chemist, Dr. Andrew Lewis, Chief Scientific Officer, and Dr. Andrew Parker, Senior Drug Development Consultant, discussed the growing interest in oral peptides and common challenges faced in precli...
Learn moreNew preclinical technology screening service available to support clients through earlier stages of drug development.
Learn more“Quotient Sciences is the first CDMO to successfully install and qualify the GMP Biofoundary-in-a-Box system. We’re delighted to be working with them to enable the development of new RNA-based therapies and accelerate the delivery of existi...
Learn moreMartin discusses streamlined formulation strategy, benefits of simplified formulation, and why working together with experts is key a to accelerating FiH trials.
Learn moreThe Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations (CROs).
Learn more